Matches in Wikidata for { <http://www.wikidata.org/entity/Q70424991> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q70424991 description "articolo scientifico (pubblicato il 1982)" @default.
- Q70424991 description "artigo científico (publicado na 1982)" @default.
- Q70424991 description "artikull shkencor i botuar më 01 janar 1982" @default.
- Q70424991 description "artículu científicu espublizáu en 1982" @default.
- Q70424991 description "im Januar 1982 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70424991 description "scientific article published on 01 January 1982" @default.
- Q70424991 description "wetenschappelijk artikel" @default.
- Q70424991 description "наукова стаття, опублікована в січні 1982" @default.
- Q70424991 description "գիտական հոդված հրատարակված 1982 թվականի հունվարի 1-ին" @default.
- Q70424991 name "The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination" @default.
- Q70424991 name "The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination" @default.
- Q70424991 name "The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination" @default.
- Q70424991 type Item @default.
- Q70424991 label "The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination" @default.
- Q70424991 label "The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination" @default.
- Q70424991 label "The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination" @default.
- Q70424991 prefLabel "The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination" @default.
- Q70424991 prefLabel "The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination" @default.
- Q70424991 prefLabel "The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination" @default.
- Q70424991 P1433 Q70424991-A8CDE41E-64B7-46D9-9199-10B1A24ED563 @default.
- Q70424991 P1476 Q70424991-03F5BF4E-8AA4-4439-B9DA-81C1B4D6411B @default.
- Q70424991 P2093 Q70424991-20A777F3-DA40-4C2B-8D82-7EC459E8B9CD @default.
- Q70424991 P2093 Q70424991-21E2F2D2-26B7-4B58-8937-9A89FD4BBB4F @default.
- Q70424991 P2093 Q70424991-63461749-28D3-460A-99DD-758C350AB151 @default.
- Q70424991 P2093 Q70424991-852F290A-E156-4F84-9DDC-35E4DF01D8A4 @default.
- Q70424991 P2093 Q70424991-AA2B59DB-E675-4767-A405-A88C0BEF1469 @default.
- Q70424991 P2093 Q70424991-B05E21D0-2C54-4610-95AD-25D8D91A7A54 @default.
- Q70424991 P2860 Q70424991-025B1F60-C110-4E3D-81F4-54FB313DA0E8 @default.
- Q70424991 P2860 Q70424991-1C5EDA1F-B880-457F-8BB2-34C05406135B @default.
- Q70424991 P2860 Q70424991-22EA8D97-F781-41AA-BF9B-ECCBD70FD78A @default.
- Q70424991 P2860 Q70424991-36FFCFF4-E8AC-40AF-ACD8-596CB597F344 @default.
- Q70424991 P2860 Q70424991-37C45FA1-C6C3-447F-9E6A-3D2CA4D23161 @default.
- Q70424991 P2860 Q70424991-4A928C5D-25F0-44F8-9A20-8F66FAC517ED @default.
- Q70424991 P2860 Q70424991-6394E214-9DBD-4E18-A26A-16FE93634287 @default.
- Q70424991 P2860 Q70424991-7D7D2FE1-3000-4051-9DC8-81CA5E71C9E1 @default.
- Q70424991 P2860 Q70424991-C48FAD6E-D159-4E62-B06B-2EDC391BDF03 @default.
- Q70424991 P2860 Q70424991-F73A2B62-42C8-4E7E-87E7-3EC61CDAA7F7 @default.
- Q70424991 P2888 Q70424991-730E8CB1-90DF-4B8C-B8B4-9D93261059DB @default.
- Q70424991 P304 Q70424991-64BEA2C0-A92D-4159-A9D8-5D25402184AC @default.
- Q70424991 P31 Q70424991-8C09DB78-E1A9-448E-93F0-A4E5625D1FA8 @default.
- Q70424991 P356 Q70424991-D5D26ECC-9E13-44D7-9ABC-62A56C9C8BC3 @default.
- Q70424991 P433 Q70424991-31BC2F63-07EA-4211-9D56-E3A2DA62F8BD @default.
- Q70424991 P478 Q70424991-33621FC4-FFBD-4FA6-8882-797B1711A653 @default.
- Q70424991 P577 Q70424991-45EE6035-1DBB-4ADB-8F92-DA1E57B6D1B3 @default.
- Q70424991 P698 Q70424991-02E80DF6-859C-4B64-BF5F-B73E1C20C82C @default.
- Q70424991 P921 Q70424991-E26B786B-4E1B-4160-BC4F-E955AAFB2AF3 @default.
- Q70424991 P356 BF00255487 @default.
- Q70424991 P698 7105384 @default.
- Q70424991 P1433 Q326137 @default.
- Q70424991 P1476 "The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination" @default.
- Q70424991 P2093 "G Kennedy" @default.
- Q70424991 P2093 "H W Van den Berg" @default.
- Q70424991 P2093 "J M Bridges" @default.
- Q70424991 P2093 "R G Shanks" @default.
- Q70424991 P2093 "R Wilson" @default.
- Q70424991 P2093 "Z R Desai" @default.
- Q70424991 P2860 Q28320650 @default.
- Q70424991 P2860 Q28331786 @default.
- Q70424991 P2860 Q34263753 @default.
- Q70424991 P2860 Q40111944 @default.
- Q70424991 P2860 Q41807860 @default.
- Q70424991 P2860 Q42231739 @default.
- Q70424991 P2860 Q42241620 @default.
- Q70424991 P2860 Q66912755 @default.
- Q70424991 P2860 Q71393873 @default.
- Q70424991 P2860 Q77000667 @default.
- Q70424991 P2888 bf00255487 @default.
- Q70424991 P304 "215-219" @default.
- Q70424991 P31 Q13442814 @default.
- Q70424991 P356 "10.1007/BF00255487" @default.
- Q70424991 P433 "2" @default.
- Q70424991 P478 "8" @default.
- Q70424991 P577 "1982-01-01T00:00:00Z" @default.
- Q70424991 P698 "7105384" @default.
- Q70424991 P921 Q323936 @default.